Talazoparib, a new precision drug, can keep cancer in check in some men with advanced prostate cancer who have run out of options, a phase II clinical trial shows.
Aug 23, 2021
0
129
An accurate assessment of a patient's kidney function is critical for determining eligibility for anticancer treatments. In a paper published today in The Lancet Oncology, University of Pittsburgh Schools of the Health Sciences ...
Aug 13, 2021
0
7
Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research group has published a ...
Aug 13, 2021
0
288
Researchers from Cleveland Clinic, Case Western Reserve University School of Medicine and Moffitt Cancer Center have found that the genomic adjusted radiation dose (GARD) may be used to personalize radiotherapy (RT) to maximize ...
Aug 5, 2021
0
41
Australian cancer patients kept up their pharmaceutical treatments during last year's COVID-19 lockdowns, a big data study from UNSW Sydney shows.
Aug 3, 2021
0
99
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia (CLL), according to a Northwestern Medicine clinical trial ...
Aug 2, 2021
0
194
CanStaging⁺, a user-friendly tool aimed at facilitating the recording of comparable cancer staging data worldwide, has been launched.
Aug 2, 2021
0
0
A novel therapy engineered by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, according to results from a recent phase I clinical trial ...
Jul 30, 2021
0
79
Scientists at St. Jude Children's Research Hospital are working with colleagues in China to develop better therapy for childhood acute lymphoblastic leukemia (ALL). Results from a large phase 3 noninferiority clinical trial ...
Jul 28, 2021
0
284
MUSC Hollings Cancer Center was one of 28 clinical sites around the world that participated in the LOTIS-2 trial to test the efficacy of Loncastuximab tesirine, a promising new treatment for aggressive B-cell lymphoma. The ...
Jul 23, 2021
0
81
